Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Genentech
Biotech
Roche oral SERD's 1st-line miss spurs new adjuvant trial
Roche plans to start a new study to test the combination of giredestrant with a CDK4/6 inhibitor for the adjuvant treatment of early breast cancer.
Angus Liu
Jun 2, 2026 12:45pm
BioCryst scraps eye drug to focus on rare diseases
May 6, 2026 10:40am
Roche unpacks death imbalance in multiple sclerosis ph. 3 trials
Apr 21, 2026 7:15pm
Roche takes ‘leap of faith’ with bet on C4T’s protein degraders
Apr 9, 2026 7:00am
Genentech drug fails rare disease study, raising obesity questions
Mar 20, 2026 2:11pm
Genentech shreds RIPK1 inhibitor after ph. 2 failure
Mar 19, 2026 2:48pm
